We are live on
!
Find out more
ADMA Biologics
ADMA
ADMA
23 hedge funds and large institutions have $54.7M invested in ADMA Biologics in 2017 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
400% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 2
110% more capital invested
Capital invested by funds: $26M → $54.7M (+$28.6M)
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
49.85% more ownership
Funds ownership: 49.15% → 99% (+50%)
21% more funds holding
Funds holding: 19 → 23 (+4)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
23
Holders Change
+4
Holders Change %
+21.05%
% of All Funds
0.52%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
9
Increased
10
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PA
Perceptive Advisors
New York
|
+$8.67M |
| 2 |
CCM
Consonance Capital Management
New York
|
+$5.86M |
| 3 |
BC
Broadfin Capital
New York
|
+$3.08M |
| 4 |
6CM
683 Capital Management
New York
|
+$2.66M |
| 5 |
MWVC
Morgens Waterfall Vintiadis & Co
New York
|
+$1.4M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$263K |
| 2 |
Bank of New York Mellon
New York
|
-$66K |
| 3 |
Renaissance Technologies
New York
|
-$63K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$36K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$10K |
